CLCN7
H(+)/Cl(-) exchange transporter 7
Also known as: CLC-7, CLC7, CLCN7_HUMAN, OPTA2, PPP1R63
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51798
- Gene
- CLCN7
- Ensembl
- ENSG00000103249
- Chromosome
- 16
- Canonical length
- 805 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The product of this gene belongs to the CLC chloride channel family of proteins. Chloride channels play important roles in the plasma membrane and in intracellular organelles. This gene encodes chloride channel 7. Defects in this gene are the cause of osteopetrosis autosomal recessive type 4 (OPTB4), also called infantile malignant osteopetrosis type 2 as well as the cause of autosomal dominant osteopetrosis type 2 (OPTA2), also called autosomal dominant Albers-Schonberg disease or marble disease autosoml dominant. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. OPTA2 is the most common form of osteopetrosis, occurring in adolescence or adulthood. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
805 residues, UniProt reviewed canonical sequence.
>P51798|CLCN7
1 MANVSKKVSW SGRDRDDEEA APLLRRTARP GGGTPLLNGA GPGAARQSPR SALFRVGHMS
61 SVELDDELLD PDMDPPHPFP KEIPHNEKLL SLKYESLDYD NSENQLFLEE ERRINHTAFR
121 TVEIKRWVIC ALIGILTGLV ACFIDIVVEN LAGLKYRVIK GNIDKFTEKG GLSFSLLLWA
181 TLNAAFVLVG SVIVAFIEPV AAGSGIPQIK CFLNGVKIPH VVRLKTLVIK VSGVILSVVG
241 GLAVGKEGPM IHSGSVIAAG ISQGRSTSLK RDFKIFEYFR RDTEKRDFVS AGAAAGVSAA
301 FGAPVGGVLF SLEEGASFWN QFLTWRIFFA SMISTFTLNF VLSIYHGNMW DLSSPGLINF
361 GRFDSEKMAY TIHEIPVFIA MGVVGGVLGA VFNALNYWLT MFRIRYIHRP CLQVIEAVLV
421 AAVTATVAFV LIYSSRDCQP LQGGSMSYPL QLFCADGEYN SMAAAFFNTP EKSVVSLFHD
481 PPGSYNPLTL GLFTLVYFFL ACWTYGLTVS AGVFIPSLLI GAAWGRLFGI SLSYLTGAAI
541 WADPGKYALM GAAAQLGGIV RMTLSLTVIM MEATSNVTYG FPIMLVLMTA KIVGDVFIEG
601 LYDMHIQLQS VPFLHWEAPV TSHSLTAREV MSTPVTCLRR REKVGVIVDV LSDTASNHNG
661 FPVVEHADDT QPARLQGLIL RSQLIVLLKH KVFVERSNLG LVQRRLRLKD FRDAYPRFPP
721 IQSIHVSQDE RECTMDLSEF MNPSPYTVPQ EASLPRVFKL FRALGLRHLV VVDNRNQVVG
781 LVTRKDLARY RLGKRGLEEL SLAQTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLCN7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 37 nTPM
- bone marrow: 28 nTPM
- skeletal muscle: 28 nTPM
- spleen: 27 nTPM
- cerebellum: 24 nTPM
- thyroid gland: 23 nTPM
Single-cell type
- melanocytes: 112 nCPM
- retinal horizontal cells: 70 nCPM
- hofbauer cells: 57 nCPM
- proximal tubule cells: 56 nCPM
- retinal amacrine cells: 54 nCPM
- monocytes: 49 nCPM
Immune cell
- non-classical monocyte: 3.4 nTPM
- intermediate monocyte: 2.4 nTPM
- classical monocyte: 1.5 nTPM
- myeloid DC: 1.2 nTPM
- plasmacytoid DC: 1.1 nTPM
- eosinophil: 1 nTPM
Brain region
- pons: 54 nTPM
- midbrain: 52 nTPM
- choroid plexus: 51 nTPM
- thalamus: 46 nTPM
- medulla oblongata: 46 nTPM
- cerebral cortex: 44 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLCN7.
Disease | AllUniProt
Conditions CLCN7 is implicated in, by any mechanism.
- Osteopetrosis, autosomal recessive 4 (OPTB4) MIM:611490
- Osteopetrosis, autosomal dominant 2 (OPTA2) MIM:166600
- Hypopigmentation, organomegaly, and delayed myelination and development (HOD) MIM:618541
Disease | GeneticClinVar
95 pathogenic / likely-pathogenic of 1,464 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive osteopetrosis 4
- Autosomal dominant osteopetrosis 2
- Hypopigmentation, organomegaly, and delayed myelination and development
- CLCN7-related disorder
- Disorder of bone
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.27
- gnomAD missense Z
- 2.11
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLCN7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLCN7 as an antibody target. Whether an autoantibody or antibody against CLCN7 could matter depends on whether native CLCN7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLCN7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLCN7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...